Harvard Apparatus Regenerative Technology Inc
hregen.comWhat Do They Do?
Sells dietary supplements and other personal healthcare products to consumers, and develops stem-cell treatments to regenerate damaged organs.
10-K for FY2025, filed Mar 19, 2026Our subsidiary in Hong Kong, Harvard Apparatus Regenerative Technology Limited, or Consumer Health Products, focuses on sales of consumer…View ↗
Consumer Health Products plans to include a broad range of products focused on personal healthcare including dietary supplements. These…View ↗
We are a clinical-stage biotechnology company focused on the development of regenerative medicine treatments for disorders of the…View ↗
How Do They Make Money?
A distributor pays in advance for consumer health goods, with the sale counted when the company provides them; hospitals are expected to buy regenerative implants.
10-K for FY2025, filed Mar 19, 2026
-
10-K for FY2025, filed Mar 19, 2026
FY2025 revenue by reportable segment ↗
$704K
-
10-K for FY2025, filed Mar 19, 2026
$704K ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Regenerative Biotech
Sold outright
|
0.0% |
Regenerative Biotech, FY2025
$0 Sources
|
Sold outright |
|
Consumer Health Products
Sold outright
10-K for FY2025, filed Mar 19, 2026 |
100% |
Consumer Health Products, FY2025
$704K Sources
|
Sold outright |
Who Are Their Customers?
Health Regen holds exclusive global distribution rights for Consumer Health Products, which are marketed to the general public through online sales; hospitals are expected to buy regenerative implants.
10-K for FY2025, filed Mar 19, 2026In October 2024, the Company entered into an exclusive distribution agreement (the “Distribution Agreement”) with Health Regen, Inc., of…View ↗
Consumer Health Products plans to include a broad range of products focused on personal healthcare including dietary supplements. These…View ↗
We further expect to be paid by the hospital that buys the product from us. Finally, we expect that the hospital would seek reimbursement…View ↗
10-K for FY2025, filed Mar 19, 2026
Health Regen accounted for 96% and 54% of total product revenue in 2025 and 2024, respectively. Additionally, the distributor represented…View ↗
Do Revenues Turn Into Profits?
No. It lost $6.9M in FY2025.
10-K for FY2025, filed Mar 19, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 13, 2026
−$1.7MView ↗
- ▼ −7% (Loss)
- vs −$1.8M in Q2 FY2025
10-Q for Q2 FY2026, filed Aug 13, 2026
Open tableView ↗
Consumer health products
The latest report adds consumer health products, including dietary supplements marketed to the general public, alongside the earlier regenerative-medicine development business.
10-K for FY2022, filed Mar 30, 2023 10-K for FY2025, filed Mar 19, 2026We are a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastro-intestinal system and…View ↗
Loading...
